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Aldose reductase (EC 1.1.1.2 1) has been implicated in a variety of diabetic complications. Here we present 
the first primary sequence data for the rat lens enzyme, obtained by amino acid and cDNA analysis. We 
have found structural similarities with another NADPH-dependent oxidoreductase: human liver aldehyde 
reductase (EC 1.1.1.2). The identity between these two enzymes is 50%. Both enzymes hare approx. 4&50% 
homology with p-crystallin, a major lens protein present only in the frog, Rana pipiens. We propose that 
aldose reductase, aldehyde reductase and p-crystallin are members of a superfamily of related proteins. 
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1. INTRODUCTION 
Aldose reductase (AR; EC 1.1.1.21) catalyzes 
the reduction of a variety of sugars to sugar 
alcohols. In diabetes and galactosemia, increased 
AR activity leads to high levels of sorbitol and 
galactitol, respectively, in the cells of many tissues 
[ 11. Accumulation of sugar alcohols has been 
shown to cause osmotic cataracts in the lens [2-41. 
Aldose reductase is also thought to play a key role 
in diabetic complications of three other target 
tissues, namely, nerve, kidney and retina [5-91. 
Currently, a varieti of AR inhibitors are being 
tested as a possible new treatment modality for 
diabetics, although side effects are always a con- 
cern. 
In order to study the function and tissue 
specificity of AR and expand on drug designs for 
AR inhibitors, we initiated a study of the structure 
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of AR using polypeptide and DNA sequencing. 
While obtaining the sequence for AR, we found 
considerable homology with another NADPH- 
dependent reductase: aldehyde reductase (EC 
1.1.1.2). In addition, both reductases were found 
to share homologies with frog lens e-crystallin, 
adding to the number of crystallins known to be 
related to enzymes [lo-111. 
In this article, we present sequence data which 
compare AR, aldehyde reductase and Q-crystallin 
and discuss the functional and evolutionary rela- 
tionships of these proteins. In addition, we present 
the partial nucleotide and amino acid sequence for 
AR. 
2. MATERIALS AND METHODS 
N-terminal partial peptide sequence was deter- 
mined as described [ 121 using tryptic and cyanogen 
bromide-cleaved peptide fragments from purified 
rat lens AR [ 131 (see fig. 1). Oligonucleotide probes 
designed from this sequence were used to screen a 
hgt 11 rat lens cDNA library (Clonetech, Palo Alto, 
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Fig. 1. The sequence of the 1206 bp cDNA clone for rat lens AR. The upper line shows the predicted amino acid sequence 
with the positions of peptides determined by amino acid sequencing indicated in black. Peptides a, d, e and fare tryptic 
peptide fragments and peptides b and c are CNBr-cleaved fragments. The first three amino acids of peptide b could 
not be determined by protein sequence. The lower line shows the nucleotide sequence and is numbered. We found two 
discrepancies between the peptide sequence and the predicted amino acid sequence. The amino acids obtained from the 
peptide sequence that were different are: S at codon position 40 and W at position 66. 
CA). Three oligonucleotides were made using two 
different approaches [14]. One oligo (20-mer) was 
made with all possible codons (oligo 696 = TAT- 
(C)CAA(G)AAT(C)GAA(G)AAA(G)TGGGT), re- 
sulting in a mixture of 32 different combinations. 
The other two oligos were much longer (35 and 
36-mer) and had only one combination based on 
codon usage tables [15]. The sequences are: oligo 
697 = TCCGCCCAGGTGTACCAGAACGAGA- 
AGTGGGTGGG and oligo 698 = CTGGACT- 
ACCTGGACCTGTACCTGATGCACTGGCCC. 
The first approach dilutes the probe but guarantees 
the correct combination. In the latter approach, 
the uncertainty of each codon is not as critical, 
since increased probe length confers probe 
specificity. Indeed, comparison of our final se- 
quence shows that both probes were about 90% 
correct. Statistically, a 36-mer probe should be 
85% correct for specific hybridization [14]. Some 
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of the codon error was due to discrepancies in our 
initial amino acid sequence. For oligo 697, the 
codon TCC for serine should have been TGC (cys- 
teine); the codon TGG for tryptophan should have 
been GAG (glutamic acid). For oligo 698, the 
codon ATG for methionine should have been ATT 
(isoleucine). The sequence for oligo 698 was based 
partially on highly conserved sequences from 
aldehyde reductase and e-crystallin. 
The cDNA clone 1OQ was subcloned into the 
EcoRI site of Ml3 and sequenced using the 
dideoxy chain termination method of Sanger (as 
described in the BRL Ml3 cloning/dideoxy se- 
quencing manual). In addition to the universal 
Ml3 primer, synthetic primers designed from the 
sequence were used. These primers were synthe- 
sized using an Applied Biosystems DNA syn- 
thesizer (model 360B). The cDNA insert was 
completely sequenced in both directions. 
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Fig.2. Comparison of the amino acid sequences of human liver aldehyde reductase (ALD), rat lens aldose reductase 
(AR) and frog lens e-crystallin (RHO). Dots represent matches between AR and aldehyde reductase or between AR 
and q-crystallin. Some variation in the aldehyde reductase sequence has been observed by Wermuth et al. [18]. Position 
177 is either E or V and position 209 is either Y or C. The former choices are derived from protein sequencing. 
3. RESULTS AND DISCUSSION 
Using the oligonucleotide probes designed from 
the partial amino acid sequence, 15 cDNA clones 
were isolated from a rat lens hgt 11 library. One of 
these, lOQ, gave hybridization with both probes 
697 and 698. Probe 696 is a shorter version of 697 
and was not used in this particular screening. The 
cDNA insert from IOQ was isolated and complete- 
ly sequenced (fig. 1). The insert is 1206 bp in length 
with an open reading frame covering the first 854 
bases and encoding 284 amino acids (or a 
molecular size of approx. 32300 Da). This cor- 
responds to about 85% of the full size expected for 
211 
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AR. All of the AR peptides which were sequenced 
can be accounted for in the 284 amino acids en- 
coded by the open reading frame, indicating that 
1 OQ encodes rat lens AR. A polyadenylation signal 
is observed at position 1187, suggesting that the 
3 ‘-untranslated region of the cDNA is virtually 
complete. 
The partial primary structure of AR was com- 
pared with the protein data bank of the National 
Biomedical Research Foundation. We found a 
significant similarity (50%) between frog lens e- 
crystallin and the sequence for AR. The e- 
crystallin protein sequence deduced from a partial 
cDNA sequence is about 3/4 of the full size [ 16,171. 
We also discovered that rat lens AR has 50% iden- 
tity with human liver aldehyde reductase, which 
was recently sequenced in its entirety at the amino 
acid level [ 181. There was slightly less similarity 
between aldehyde reductase and e-crystallin 
(43%). The similarities among these three proteins 
are shown in fig.2; the numbering is according to 
the complete sequence of aldehyde reductase. 
Highly conserved areas can be seen. Local iden- 
tities as high as 84% were observed, in spite of dif- 
ferent species and different tissues. For example, 
there are 16 out of 19 amino acids in common be- 
tween AR and aldehyde reductase beginning at 
position 96. Another striking area of similarity ex- 
ists between AR and e-crystallin beginning at posi- 
tion 169, where 13 amino acids in a row are 
conserved between these two proteins. 
This degree of similarity clearly suggests that all 
three proteins belong to the same superfamily with 
related structures and evolutionary origins. The 
relationship between AR and aldehyde reductase is 
perhaps not surprising, since both enzymes exhibit 
overlapping substrate specificity and similar func- 
tion. Both have been implicated in models of the 
secondary complications seen in diabetes, with the 
potential to elevate sugar alcohol levels. 
Recently, the active sites for both aldehyde 
reductase and AR have been reported [ 191. The 
sites are homologous and include a tetrapeptide 
with the sequence I-P-K-S. Our sequence data 
show that this tetrapeptide is part of a highly con- 
served carboxy-terminal region, beginning at posi- 
tion 259. The tetrapeptide sequence is only 
partially conserved in e-crystallin. 
The relationship between e-crystallin, a major 
structural component of the lens in the genus Rana 
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pipiens, and a superfamily of oxidoreductases, is 
consistent with other observations that so-called 
‘taxon-specific’ crystallins are very closely related 
to normal cellular enzymes. c-Crystallin in the 
duck appears to be identical to lactate dehydro- 
genase-B4 in terms of sequence and enzyme activi- 
ty [lo]. Other close relationships have been 
observed between other crystallins and enzymes 
[l I]. AR activity was measured in the frog lens, 
but only low levels were detected. e-Crystallin may 
lack enzyme activity altogether, or it may have a 
quite different substrate specificity; in either case 
this may be reflected in the sequence divergence at 
the proposed active site. 
The roles of AR and aldehyde reductase in nor- 
mal metabolism and under conditions of hyper- 
glycemia are currently under intense investigation. 
Several potential therapeutic agents designed as 
AR inhibitors are under development and a de- 
tailed understanding of the structure, function and 
expression of this enzyme is required. The se- 
quence data presented here should provide useful 
tools for this endeavor. 
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